Concepedia

Publication | Open Access

Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies

32

Citations

44

References

2022

Year

References

YearCitations

Page 1